Filing Details
- Accession Number:
- 0001209191-14-036751
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-23 17:21:33
- Reporting Period:
- 2014-05-21
- Filing Date:
- 2014-05-23
- Accepted Time:
- 2014-05-23 17:21:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1562070 | Umari Abdul-Wahab | C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-21 | 250,000 | $0.00 | 0 | No | 4 | S | Indirect | See Footnotes |
| Common Stock | Disposition | 2014-05-22 | 250,000 | $0.00 | 0 | No | 4 | S | Indirect | See Footnotes |
| Common Stock | Disposition | 2014-05-23 | 45,000 | $0.00 | 0 | No | 4 | S | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2014-05-23 | 575,758 | $0.00 | 0 | No | 4 | X | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2014-05-23 | 313,341 | $0.00 | 0 | No | 4 | X | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2014-05-23 | 110,901 | $0.00 | 0 | No | 4 | X | Indirect | See Footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | X | Indirect | See Footnotes |
| No | 4 | X | Indirect | See Footnotes |
| No | 4 | X | Indirect | See Footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants | Disposition | 2014-05-23 | 575,758 | $0.00 | 575,758 | $0.79 |
| Common Stock | Warrants | Disposition | 2014-05-23 | 313,341 | $0.00 | 313,341 | $0.79 |
| Common Stock | Warrants | Disposition | 2014-05-23 | 110,901 | $0.00 | 110,901 | $0.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-05-07 | 2014-06-01 | No | 4 | X | Indirect |
| 0 | 2013-05-07 | 2014-06-01 | No | 4 | X | Indirect |
| 0 | 2013-05-07 | 2014-06-01 | No | 4 | X | Indirect |
Footnotes
- Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"), of which Pillar Invest Corporation ("Pillar GP") is the general partner.
- Abdul-Wahab Umari is a director of Pillar GP and serves as the representative of a Pillar I, Pillar II and Pillar GP on the Issuer's board of directors. Mr. Umari disclaims Section 16 beneficial ownership of the Pillar I Warrants, Pillar II Warrants and the Besancon Warrants (including in each case the common stock underlying such warrants) and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. Umari owns directly 67,304 shares of common stock of the Issuer.
- Warrants beneficially owned and exercised for shares of common stock by Pillar I, of which Pillar GP is the general partner (the "Pillar I Warrants").
- Warrants beneficially owned and exercised for shares of common stock by Pillar Pharmaceuticals II, L.P. ("Pillar II"), of which Pillar GP is the general partner (the "Pillar II Warrants") of the Issuer.
- Warrants beneficially owned and exercised for shares of common stock by Participations Besancon, a fund advised by Pillar GP (the "Besancon Warrants").
Billionaire Hedge Funds
